HOUSTON, Aug. 04, 2022 Salarius Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing therapies for patients with cancer in need of new treatment options, announces the. | August 4, 2022
Faron Pharmaceuticals said it was encouraged by survival rates among advanced-stage cancer patients who responded to treatment from its immunotherapy drug.
Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in animal models of the disease, according to a preclinical study by investigators at Weill Cornell Medicine.
Immune therapy targets cells that cause leukemia relapse miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Summit Bank Announces New Board of Advisors for Portland Metropolitan Office apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.